You are using an outdated browser. For a faster, safer browsing experience, upgrade for free today.

Life & Medical Care

Global Chemotherapy Induced Peripheral Neuropathy Treatment Market Study 2016-2026, by Segment (APX-3330, BR-297, … …), by Market (Clinic, Hospital, … …), by Company (Achelios Therapeutics Inc, Advinus Therapeutics Ltd, … …)

Summary

The global Chemotherapy Induced Peripheral Neuropathy Treatment market will reach Volume Million USD in 2019 and with a CAGR xx% between 2020-2026.
Product Type Coverage (Market Size & Forecast, Major Company of Product Type etc.):
APX-3330
BR-297
Cannabidiol
Dimiracetam
Others
Demand Coverage (Market Size & Forecast, Consumer Distribution):
Clinic
Hospital
Others
Company Coverage (Sales data, Main Products & Services etc.):
Achelios Therapeutics Inc
Advinus Therapeutics Ltd
Apollo Endosurgery Inc
Aptinyx Inc
Asahi Kasei Pharma Corp
Can-Fite BioPharma Ltd
Celgene Corp
DermaXon LLC
Eisai
Immune Pharmaceuticals Inc
INSYS Therapeutics Inc
Kineta Inc
KPI Therapeutics Inc
Krenitsky Pharmaceuticals Inc
MAKScientific LLC
Metys Pharmaceuticals AG
Midatech Pharma US Inc
Mundipharma International Ltd
Nemus Bioscience Inc
Neurocentrx Pharma Ltd
Panacea Pharmaceuticals Inc
PeriphaGen Inc
PharmatrophiX Inc
PledPharma AB
Sova Pharmaceuticals Inc
Virobay Inc
WEX Pharmaceuticals Inc
Major Region Market
North America
Europe
Asia-Pacific
South America
Middle East & Africa
Table of Content
1 Industry Overview
1.1 Chemotherapy Induced Peripheral Neuropathy Treatment Industry
1.1.1 Overview
1.1.2 Products of Major Companies
1.2 Market Segment
1.2.1 Industry Chain
1.2.2 Consumer Distribution
1.3 Price & Cost Overview
2 Chemotherapy Induced Peripheral Neuropathy Treatment Market by Type
2.1 By Type
2.1.1 APX-3330
2.1.2 BR-297
2.1.3 Cannabidiol
2.1.4 Dimiracetam
2.1.5 Others
2.2 Market Size by Type
2.3 Market Forecast by Type
3 Global Market Demand
3.1 Segment Overview
3.1.1 Clinic
3.1.2 Hospital
3.1.3 Others
3.2 Market Size by Demand
3.3 Market Forecast by Demand
4 Major Region Market
4.1 Global Market Overview
4.1.1 Market Size & Growth
4.1.2 Market Forecast
4.2 Major Region
4.2.1 Market Size & Growth
4.2.2 Market Forecast
5 Major Companies List
5.1 Achelios Therapeutics Inc (Company Profile, Sales Data etc.)
5.2 Advinus Therapeutics Ltd (Company Profile, Sales Data etc.)
5.3 Apollo Endosurgery Inc (Company Profile, Sales Data etc.)
5.4 Aptinyx Inc (Company Profile, Sales Data etc.)
5.5 Asahi Kasei Pharma Corp (Company Profile, Sales Data etc.)
5.6 Can-Fite BioPharma Ltd (Company Profile, Sales Data etc.)
5.7 Celgene Corp (Company Profile, Sales Data etc.)
5.8 DermaXon LLC (Company Profile, Sales Data etc.)
5.9 Eisai (Company Profile, Sales Data etc.)
5.10 Immune Pharmaceuticals Inc (Company Profile, Sales Data etc.)
5.11 INSYS Therapeutics Inc (Company Profile, Sales Data etc.)
5.12 Kineta Inc (Company Profile, Sales Data etc.)
5.13 KPI Therapeutics Inc (Company Profile, Sales Data etc.)
5.14 Krenitsky Pharmaceuticals Inc (Company Profile, Sales Data etc.)
5.15 MAKScientific LLC (Company Profile, Sales Data etc.)
5.16 Metys Pharmaceuticals AG (Company Profile, Sales Data etc.)
5.17 Midatech Pharma US Inc (Company Profile, Sales Data etc.)
5.18 Mundipharma International Ltd (Company Profile, Sales Data etc.)
5.19 Nemus Bioscience Inc (Company Profile, Sales Data etc.)
5.20 Neurocentrx Pharma Ltd (Company Profile, Sales Data etc.)
5.21 Panacea Pharmaceuticals Inc (Company Profile, Sales Data etc.)
5.22 PeriphaGen Inc (Company Profile, Sales Data etc.)
5.23 PharmatrophiX Inc (Company Profile, Sales Data etc.)
5.24 PledPharma AB (Company Profile, Sales Data etc.)
5.25 Sova Pharmaceuticals Inc (Company Profile, Sales Data etc.)
5.26 Virobay Inc (Company Profile, Sales Data etc.)
5.27 WEX Pharmaceuticals Inc (Company Profile, Sales Data etc.)
6 Conclusion